Roche Gains With Tecentriq IMpower131 NSCLC Data, But For How Long?

Lung cancer
Roche Released Positive IMpower131 Data In Initial Squamous Cell Lung Cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D